Global Flourescent in Situ Hybridization (FISH) Probe Market: Increasing Cytogenic-based Illness will Enhance the Market Growth

Flourescent in Situ Hybridization (FISH) Probe Market

Fluorescence in situ hybridization (FISH) is a molecular cytogenetic process which usually uses fluorescent samples that attach with a high degree of sequence complementarity to only those parts of a nucleic acid chain. This approach provides scientists with a new way of visualizing and measuring the genetic material in a single cell, including specific genes or parts of genes. It is an essential way of understanding a wide range of chromosomal and other genetic mutations.  They are also used detect specific RNA targets in cells, tissue cells, and circulating tumor cells. Some of the common technologies which are used FISH probe such as DISH, CISH, and FISH. Researchers usually use three different types of FISH probes such as alphoid or centromeric repeat probes, locus specific probes, and whole chromosome probes.

Access Full Report at

Some of the factors responsible for the growth of Global Flourescent in Situ Hybridization (FISH) Probe Market market:

  • Increase in the cytogenic-based illness, genetic abnormalities including carcinogenesis: Cytogenetics is a genetic division concerned with how the chromosomes contribute to the behavior of the cells, particularly their behavior during mitosis and meiosis. Clinical cytogenetics has a significant impact on the treatment regulation and prevention of many chromosome aberrations-induced disorders. Tumorigenesis is cancer development that turns normal cells into cancer cells. Changes in cell, genetic, and epigenetic levels and abnormal cell division characterize the process

  • Increase in the R&D investments for in-vitro diagnosis: Tests conducted on samples such as blood and tissue obtained from the human body are in vitro diagnostics. They are usually used to detect diseases that have the ability to track the overall health of the patient. Precision medicine may also use in vitro diagnostics to classify patients who are likely to benefit from different therapies or treatments. These in vitro diagnoses may include sequencing trials of the next generation that scan the DNA of a person to detect genomic combinations

The global flourescent in situ hybridization (fish) probe market is segmented on the basis of technology as FISH, CISH, & DISH; type as DNA, & RNA; application as cancer research, genetic diseases, & other and end user as research, clinical, and companion diagnostics

Some of the launches and acquisition in Global Flourescent in Situ Hybridization (FISH) Probe Market are:

  • In July 2019, Bio-Techne announced the launch of their RNAscope HiPlex Assay which will help the company to enhance their Advanced Cell Diagnostics-branded RNAscope platform. The RNAscope HiPlex Assay allows researchers to gain more insight into cellular processes and structures by combining a simple workflow with the ability to identify up to 12 RNA targets simultaneously. The RNAscope HiPlex Assay enables a researcher to add histological background to the information from scRNAseq, which is necessary to fully understand the biology of different cell populations
  • In April 2018, Agilent Technologies Inc announced the launch of EBER RNA CISH, Kappa, and Lambda mRNA CISH probes which will help the company to enhance their in situ hybridization probes. The launch of the drug further improves the diagnostic abilities of the Dako Omnis instrumentation, which can be used for simultaneous analysis of chromogenic in situ hybridization (CISH), fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC)

“According to Data Bridge Market Research, global flourescent in situ hybridization   probe market is expected to register a substantial CAGR of 6.6% in the forecast period of 2019-2026”

Few of the major market competitors currently working in the global flourescent in situ hybridization   probe market are Oxford Gene Technology, Agilent Technologies Inc, PerkinElmer Inc,, Horizon Discovery Group plc, BioDot,  Sysmex Singapore Pte. Ltd, ADS Biotech Inc., Thermo Fisher Scientific, Abnova Corporation,  LGC Biosearch Technologies, F. Hoffmann-La Roche Ltd, Biocare Medical,LLC, QIAGEN, Bio-Rad Laboratories, Creative BioMart, MetaSystems, Applied Spectral Imaging, Leica Biosystems Nussloch GmbH, Tocris Bioscience, Empire Genomics, LLC among others.

Increasing chronic diseases and growing demand for IVD due to their high reliability and rapidity of the FISH probe technique will also accelerate the growth. DNA-based diagnostics are becoming increasingly popular in medical diagnostics to establish suspected diseases caused by pathogen or bacteria. Rising genetic disorders such as Acute Lymphoblastic Leukemia will also enhance the market growth. These are some of the factors which are creating new opportunities in the growth and development of this market.

Browse in Healthcare Related Reports@